|
SERTAD2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.01640000047676E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.038900E-04 |
| Normal-vs-Stage2 |
1.242220E-02 |
| Normal-vs-Stage3 |
6.162900E-04 |
| Normal-vs-Stage4 |
9.380000E-02 |
| Stage1-vs-Stage2 |
4.207200E-01 |
| Stage1-vs-Stage3 |
1.554550E-01 |
| Stage1-vs-Stage4 |
2.072000E-01 |
| Stage2-vs-Stage3 |
7.057600E-01 |
| Stage2-vs-Stage4 |
5.961200E-01 |
| Stage3-vs-Stage4 |
7.435400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.63941999999917E-05 |
| Normal-vs-AfricanAmerican |
1.455290E-03 |
| Normal-vs-Asian |
1.778380E-01 |
| Caucasian-vs-AfricanAmerican |
7.610800E-01 |
| Caucasian-vs-Asian |
8.212600E-01 |
| AfricanAmerican-vs-Asian |
6.993000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.599770E-04 |
| Normal-vs-Female |
5.75129999957902E-07 |
| Male-vs-Female |
5.042100E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.368840E-01 |
| Normal-vs-Extreme_Weight |
3.817000E-03 |
| Normal-vs-Obese |
3.9094999999989E-05 |
| Normal-vs-Extreme_Obese |
2.130800E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.407200E-01 |
| Normal_Weight-vs-Obese |
2.990100E-02 |
| Normal_Weight-vs-Extreme_Obese |
5.205200E-01 |
| Extreme_Weight-vs-Obese |
1.646410E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.346400E-01 |
| Obese-vs-Extreme_Obese |
5.315400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.815800E-03 |
| Normal-vs-Age(41-60Yrs) |
1.25049999999405E-06 |
| Normal-vs-Age(61-80Yrs) |
1.623070E-03 |
| Normal-vs-Age(81-100Yrs) |
2.138800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.809600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.366240E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.963900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.450400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.601600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.761000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.37440000000677E-06 |
| Normal-VS-Type2 PRCC |
2.498000E-02 |
| Normal-VS-KIRP CIMP |
3.279700E-03 |
| Normal-VS-Unclassified PRCC |
2.355700E-03 |
| Type1 PRCC-VS-Type2 PRCC |
2.054600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.397300E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
2.394000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.807800E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
8.270300E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
9.057900E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.885990E-02 |
| Normal-vs-N1 |
3.763800E-03 |
| Normal-vs-N2 |
3.502600E-01 |
| N0-vs-N1 |
6.686100E-02 |
| N0-vs-N2 |
5.240200E-01 |
| N1-vs-N2 |
7.612600E-01 |
|
|
